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Life-Saving Naloxone from Pharmacies
More dispensing needed despite progress
2x
The number of 
prescriptions for 
naloxone doubled  
from 2017 to 2018.
1 in 70
Only 1 naloxone 
prescription is 
dispensed for  
every 70 high-dose 
opioid prescriptions. 
3x
Rural counties are 
nearly 3 times more 
likely to be ranked 
low dispensing than 
metropolitan counties.
Overview:
About 48,000 US drug overdose deaths involved 
opioids in 2017. Naloxone is a life-saving 
medication that can reverse the effects of an 
opioid overdose. Pharmacists and other healthcare 
providers play a critical role in ensuring patients 
receive naloxone. Many states have laws that 
allow pharmacists to dispense naloxone without a 
prescription (called standing orders), which have 
contributed to lowering deaths. Dispensing has 
increased in recent years, but more work needs to 
be done, particularly in rural counties.  
Improvements could be made by:
• Following the CDC Guideline for Prescribing 
Opioids for Chronic Pain to consider 
offering naloxone to patients receiving high 
opioid dosages (greater than or equal to 50 
morphine milligram equivalents per day). 
• Keeping naloxone in stock in pharmacies. 
• Educating patients, caregivers, and the 
community about the benefits of having 
naloxone readily available to more people.
PROBLEM:
People who may need naloxone 
are not all getting it.
There is wide variation in prescribing and dispensing 
across the US despite consistent state laws and 
recommendations. Dispensing naloxone in areas 
hardest hit by the opioid overdose epidemic can 
increase the number of overdose reversals and the 
opportunity to link overdose survivors into treatment.
Actions needed to improve access locally.
Examples include:
• Reducing insurance co-pay for patients.
• Increasing provider training and education. 
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Co-prescribing naloxone is recommended for patients at risk for opioid overdose.
9 MILLION
If each person with a high-dose opioid 
prescription were offered naloxone,  
nearly 9 million prescriptions for naloxone 
could have been dispensed in 2018.
RISK FACTORS FOR OVERDOSE
High-dose opioid prescriptions
• Opioids taken with benzodiazepines
• History of substance use disorder
• Misusing prescription opioids or using 
illicit drugs (either opioids or potentially 
contaminated with opioids)
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Many factors contribute to the problem. 
• Most (71%) of Medicare prescriptions for naloxone required a 
copay compared to 42% for commercial insurance. 
• Primary care providers only prescribed about 2 naloxone 
prescriptions for every 100 high-dose opioid prescriptions. 
• Naloxone dispensing is 25 times greater in the highest-
dispensing counties than the lowest.
CDC Guideline: https://bit.ly/2howXqN, HHS Guidance: https://bit.ly/2EEh8YO
THE WAY FORWARD 
PHARMACISTS AND OTHER 
HEALTHCARE PROVIDERS CAN:
• Monitor patients for risk of 
overdose, prescribe or dispense 
naloxone when overdose risk factors 
are present, and counsel patients 
on how to use it.
• Ensure naloxone is always available 
in pharmacies.  
• Participate in and offer naloxone 
training and education.
HEALTH INSURERS CAN:
• Reduce patient out-of-pocket costs. 
• Cover naloxone prescriptions 
without prior approval. 
STATES AND COMMUNITIES CAN:
• Work with healthcare providers to 
expand naloxone access, especially 
in rural areas.
• Promote the benefits of prescribing, 
dispensing, and carrying naloxone.
• Create harm reduction programs 
and improve access to medication-
assisted treatment for opioid  
use disorder.
EVERYONE CAN:
• Ask your doctor or pharmacist  
for a naloxone prescription if  
you or a loved one are taking  
high-dose opioids or have a 
substance use disorder. 
For more information  
1-800-CDC-INFO (232-4636) 
TTY: 1-888-232-6348 | Web: www.cdc.gov
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